分子生物学试剂

重组人AGER(晚期糖基化终产物特异性受体)

基本信息
产品名称:
重组人AGER(晚期糖基化终产物特异性受体)
英文名称:
Recombinant Human Advanced Glycosylation End Product-Specifi
国产/进口:
国产
产地/品牌:
百奥莱博
型号:
JN0555
参考报价:
总点击数:
283
更新日期:
2025-07-31
产品类别:

性能参数

特别提示:包括重组人AGER(晚期糖基化终产物特异性受体)在内,本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!


产品名称:重组人AGER(晚期糖基化终产物特异性受体)
英文名称:Recombinant Human Advanced Glycosylation End Product-Specific Receptor
产品货号:JN0555
产品规格:10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成,目的基因编码的Ala23-Ala344在C端含有His标签。

AGER质量控制:>95%(还原性SDS-PAGE)

AGER制剂:冻干品

AGER保存
冻干蛋白置于-20℃以下可长期保存,室温条件下可稳定保存3周。
复溶蛋白溶液可在4~7℃保存2~7天,可分装后置于-20℃保存三个月。

AGER复溶
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后,请根据用量分装冻存,避免反复冻融。

关于AGER
Advanced Glycosylation End Product-Specific Receptor (AGER) belongs to the immunoglobulin superfamily of cell surface molecules. It lies within the major histocompatibility complex (MHC) class III region on chromosome 6. Besides AGEs, AGER is also able to bind other ligands which is thought to result in pro-inflammatory gene activation. It is known that AGER serve as a mediator of both acute and chronic vascular inflammation in certain conditions such as atherosclerosis and in particular as a complication of diabetes. Furthermore, it plays an important role in regulating the production/expression of TNF-alpha, oxidative stress, and endothelial dysfunction in type 2 diabetes.

根据您的关注的重组人AGER(晚期糖基化终产物特异性受体),rhAGER,重组人Advanced Glycosylation End Product-Specific Receptor,rAGER,重组人晚期糖基化终产物特异性受体,重组AGER,重组人AGER,Recombinant Human Advanced Glycosylation End Product-Specific Receptor,重组Advanced Glycosylation End Product-Specific Receptor,重组晚期糖基化终产物特异性受体,您可能还对以下产品有需求:


JN0318 重组人趋化因子CCL11(Eotaxin) 10μg|50μg|500μg|1mg
JN0387 重组人白介素6受体α(IL-6Rα) 10μg|50μg|500μg|1mg
JN1904 重组小鼠补体C5 10μg|50μg|500μg|1mg
JN0634 重组人钙粘蛋白9(钙黏蛋白9)(钙粘附素9) 10μg|50μg|500μg|1mg
JN0721 重组人精氨琥珀酸合成酶(ASS1) 10μg|50μg|500μg|1mg
JN0775 重组人胶原蛋白α-1(VIII)链(COL8A1)(内皮胶原蛋白) 10μg|50μg|500μg|1mg
JN0857 重组人雌激素受体α 10μg|50μg|500μg|1mg

关注重组人AGER(晚期糖基化终产物特异性受体),rhAGER,重组人Advanced Glycosylation End Product-Specific Receptor,rAGER,重组人晚期糖基化终产物特异性受体,重组AGER,重组人AGER,Recombinant Human Advanced Glycosylation End Product-Specific Receptor,重组Advanced Glycosylation End Product-Specific Receptor,重组晚期糖基化终产物特异性受体的同时,为您推荐更多您可能感兴趣的产品:



名称:重组人富含半胱氨酸分泌蛋白3(CRISP-3)
货号:JN0517
规格:10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成,目的基因编码的Asn21-Tyr245在C端含有His标签。

CRISP-3质量控制:>95%(还原性SDS-PAGE)

CRISP-3制剂:冻干品

CRISP-3保存
冻干蛋白置于-20℃以下可长期保存,室温条件下可稳定保存3周。
复溶蛋白溶液可在4~7℃保存2~7天,可分装后置于-20℃保存三个月。

CRISP-3复溶
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后,请根据用量分装冻存,避免反复冻融。

关于CRISP-3
Cysteine-rich secretory protein 3 (CRISP-3) is a secreted protein,containing 1 SCP domain and 1 ShKT domain.It is belongs to the CRISP family. CRISP-3 is a glycoprotein that belongs to the family of cysteine-rich secretory proteins (CRISPs) which was originally discovered in human neutrophilic granulocytes. CRISP-3 is also widely distibuted in exocrine glands (salivary glands, pancreas and prostate), eosinophilic granulocytes and to a lower level in epididymis, ovary, thymus and colon. The presence of CRISP-3 in neutrophils, eosinophils and in exocrine secretions indicates a role in innate host defense. The antibody has been raised against recombinant C-terminally truncated form of CRISP-3 and recognizes both the N-glycosylated and non-glycosylated form of the mature protein.
公司简介
北京百奥莱博科技有限公司一家专注于生命科学研究领域的生物技术公司,坚持“质量至上,服务为本,全心全意助力生命科学”的理念,为广大用于提供稳定、可靠、专业的产品和服务支持,产品线包括分子生物学,细胞生物学,免疫检测,抗体,重组蛋白,血液制品等系列。“忙忙碌碌的平凡,铸就事业的不凡”。让我们携起手来,共同创造生命科学的蓬勃发展。

售后服务
相关视频
暂无

资料下载
暂无
联系方式
单位名称:
详细地址:
海淀区紫雀路33号院3号楼
qq:
570202610
联系电话:

18518407031

Email:

在线询价
*姓名:
*单位:
职位:
*手机:
*邮箱:
地址:
*地区:
资料:
需要
不需要
报价:
需要
不需要
留言:
验证码:
我希望获得多家供应商报价
首页 我的账户 立即询价 电话咨询